Hepatology, cancer, Immunology, and Neurology are just a few domains of research which have included research peptide Thymosin alpha-1 within the scope of their studies. Its relevance across a wide ...

Thymosin Alpha-1 (Tα1) is an endogenously occurring peptide originally isolated from thymic tissue, composed of 28 amino acids. It has emerged as a molecule of interest across various research domains ...

The thymosin alpha 1 (Tα1) peptide is a naturally occurring peptide largely formed from the thymus gland. It has been hypothesized to play a significant role in the control of immunological responses.

Thymosin Alpha 1 (Tα1) is a naturally occurring 28‐amino acid peptide renowned for its capacity to modulate immune responses. Extensive research has delineated its ability to enhance T-cell activation ...

Just as the coronavirus pandemic began its rapid and deadly spread across the United States, a well-known doctor named Dominique Fradin-Read told thousands of viewers tuning into an Instagram Live ...

Thymosin alpha 1, referred to as thymalfasin, is a synthetic 28-amino acid peptide with multiple biological activities primarily directed towards immune response enhancement. SciClone developed and ...

The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of thymosin alpha-1 (TA1) are reviewed. Clinical trials of TA1 for chronic hepatitis B or C have ...

Gufic Biosciences Limited (Gufic) have received DCGI approval for Thymosin Alpha-1 (Immunocin α – A Brand of Gufic for the said drug) as an add-on therapy for the treatment of moderate-to-severe COVID ...